Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Marijuana Inc (MAJI)

Marijuana Inc (MAJI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0410 +46.34%
on 01/05/26
0.0800 -25.00%
on 01/13/26
+0.0059 (+10.91%)
since 12/16/25
3-Month
0.0240 +150.00%
on 11/26/25
0.1365 -56.04%
on 10/17/25
-0.0303 (-33.55%)
since 10/16/25
52-Week
0.0240 +150.00%
on 11/26/25
0.3199 -81.24%
on 04/17/25
+0.0105 (+21.21%)
since 01/15/25

Most Recent Stories

More News
Exousia Pro Will Launch a Web Series with Our New Consultant

Dr. Marvin Hausman is joining Exousia Pro as a Consultant and will host a weekly series.

MAJI : 0.0600 (unch)
Exousia Pro Finishes Preclinical Trial for Glioblastoma Ahead of Schedule - Bolstering Orphan Drug Application

- Rigorous humanized mouse model enhances credibility and translatability of results

MAJI : 0.0600 (unch)
Exousia Pro CSO Revealed Significant Findings About the Glioblastoma Study in a Spaces Interview

A published paper shows NANOG Expression was almost 100% effective at eradicating tumor cells

MAJI : 0.0600 (unch)
Exousia Pro Offers Guidance on New Subdivisions

ORLANDO, FL / ACCESS Newswire / April 17, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other diseases, is pleased...

MAJI : 0.0600 (unch)
Exousia Pro to Deliver 500 Billion Dried Exosomes for Trade Show

Exousia Pro has a 60% margin built-in on each order of exosomes

MAJI : 0.0600 (unch)
Exousia Pro Issues Update on Name Change

ORLANDO, FLORIDA / ACCESS Newswire / April 3, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other diseases,...

MAJI : 0.0600 (unch)
Exousia Pro Has Appointed Matthew Dwyer As Its New President

ORLANDO, FL / ACCESS Newswire / April 2, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company using exosomes in the treatment of cancer and other maladies, is...

MAJI : 0.0600 (unch)
Exousia Pro Issues and Update on its FDA Orphan Drug Status

ORLANDO, FL / ACCESS Newswire / April 1, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company using exosomes in the treatment of cancer and other maladies, is...

MAJI : 0.0600 (unch)
Exousia Pro Officially Announces the Production of Plant-Based Exosomes Has Begun

Exousia Pro will be sending out samples to clients expected to place orders

MAJI : 0.0600 (unch)
Exousia Has Successfully Renegotiated Its License Agreement

ORLANDO, FL / ACCESS Newswire / March 18, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company using exosomes in the treatment of cancer and other maladies, is...

MAJI : 0.0600 (unch)

Key Turning Points

3rd Resistance Point 0.1075
2nd Resistance Point 0.0932
1st Resistance Point 0.0766
Last Price 0.0600
1st Support Level 0.0457
2nd Support Level 0.0314
3rd Support Level 0.0148

See More

52-Week High 0.3199
Fibonacci 61.8% 0.2069
Fibonacci 50% 0.1719
Fibonacci 38.2% 0.1370
Last Price 0.0600
52-Week Low 0.0240

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar